Cronos Group ( CRON -2.70% ) may have received a lot of buzz on Wall Street following its $1.8 billion equity investment from Altria, but the company's 120,000 kilos of peak annual output slide it behind some marijuana stocks with markedly lower market caps. The bulk of Cronos Group's production will derive from its 850,000-square-foot joint venture project (Cronos GrowCo) and wholly owned subsidiary, Peace Naturals. Expect Cronos to aggressively use its newfound cash pile to boost its cultivation capacity in the quarters that lie ahead.